Bruce Hammer, PhD, principal investigator at Minneapolis-based CMRR, and his team of researchers grew the bone cells and tested them with a magnetic levitation device that mimics the effects of space microgravity, or weightlessness.
Astronauts lose bone mass in space at a rate faster than individuals suffering from bone diseases like osteoporosis. Dr. Hammer believes studying the process of how this mass is lost could guide the development of new bone disease treatments.
The bone cells are being sent to the ISS to study whether the magnetic levitation device has the same effects on bone cells as space’s low-gravity environment.
“If we can demonstrate that magnetic levitation mimics microgravity, we then have a tool to do space biology on earth,” said Dr. Hammer. “This has implications for developing the next generation of drugs to remediate osteoporosis.”
More articles on supply chain:
Phoenix Children’s Hospital adopts Vizient’s services to improve supply chain
This headband isn’t for fashion— it offers migraine relief
Zimmer Biomet acquires Medtech SA
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
